Rezo Therapeutics

company

About

Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence.

Details

Last Funding Type
Series A
Last Funding Money Raised
$78M
Industries
Biotechnology,Product Research
Number Of Employee
1 - 10
Operating Status
Active
Legal Name
Rezo Therapeutics, Inc.

Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence. Rezo's proprietary platform can be used to treat a wide range of diseases. Rezo's initial focus is oncology, with plans to expand into other therapeutic areas through collaborations and partnerships.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$78M
Rezo Therapeutics has raised a total of $78M in funding over 2 rounds. Their latest funding was raised on Nov 17, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 17, 2022 Series A $78M 9 Norwest Venture Partners
Andreessen Horowitz
SR One
Detail

Investors

Number of Lead Investors
Number of Investors
3
9
Rezo Therapeutics is funded by 9 investors. Norwest Venture Partners and Andreessen Horowitz are the most recent investors.
Investor Name Lead Investor Funding Round
Norwest Venture Partners Yes Series A
Andreessen Horowitz Yes Series A
SR One Yes Series A
Alexandria Venture Investments Series A
Eli Lilly Series A
Hawktail Management Series A
Liquid 2 Ventures Series A
SVA Series A
UCSF Foundation Investment Company Series A

Employee Profiles

Number of Employee Profiles
6
Rezo Therapeutics has 6 current employee profiles, including Board member Vineeta Agarwala
Board member
Board member
Board member
Board member
Board member